Targeted tumor gene therapy based on loss of IGF2 imprinting.
Pan Y, He B, Li T, Zhu C, Zhang L, Wang B, Xu Y, Qu L, Hoffman AR, Wang S, Hu J.
Pan Y, et al. Among authors: he b.
Cancer Biol Ther. 2010 Aug 1;10(3):290-8. doi: 10.4161/cbt.10.3.12442. Epub 2010 Aug 21.
Cancer Biol Ther. 2010.
PMID: 20592487
Free PMC article.